A61K 47/6435
The peptide or protein in the drug conjugate being a connective tissue
Official title: {the peptide or protein in the drug conjugate being a connective tissue peptide, e.g. collagen, fibronectin or gelatin}
A61K47/6435 (The peptide or protein in the drug conjugate being a connective tissue) appears on 134 US grants and 207 published applications in this corpus.
Search patents in A61K- Granted patents
- 134
- Published applications
- 207
- Assignees
- 117
- Inventors
- 428
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 5 | 0 |
| 1995 | 4 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 2 |
| 2004 | 1 | 5 |
| 2005 | 0 | 2 |
| 2006 | 3 | 3 |
| 2007 | 0 | 3 |
| 2008 | 0 | 1 |
| 2009 | 0 | 4 |
| 2010 | 2 | 6 |
| 2011 | 2 | 9 |
| 2012 | 3 | 7 |
| 2013 | 5 | 19 |
| 2014 | 8 | 9 |
| 2015 | 9 | 12 |
| 2016 | 8 | 11 |
| 2017 | 6 | 7 |
| 2018 | 5 | 6 |
| 2019 | 11 | 18 |
| 2020 | 6 | 16 |
| 2021 | 5 | 12 |
| 2022 | 6 | 7 |
| 2023 | 5 | 12 |
| 2024 | 7 | 12 |
| 2025 | 8 | 10 |
| 2026 | 5 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Kidney-targeted drug delivery systems30 Jun 2026US 12,667,623 B2University of Mississippi Medical Center
- Scaffold proteins and therapeutic nanoconjugates based on nidogen9 Jun 2026US 12,649,776 B2Consorcio Centro De InvestigacióN BioméDica En Red
- Macropinocytosis selective monobody-drug conjugates2 Jun 2026US 12,642,859 B2New York University
- CD71 binding fibronectin type III domains31 Mar 2026US 12,589,159 B2ARO Biotherapeutics Company
- Stabilized fibronectin based scaffold molecules20 Jan 2026US 12,529,165 B2Bristol-Myers Squibb Company
- Nanostructured drug delivery system as a multifunctional platform for therapy24 Sep 2026US 2026/0284222 A1Universidade De Coimbra
- Membrane translocation domains and uses thereof10 Sep 2026US 2026/0265343 A1Ohio State Innovation Foundation
- Methods for producing stable human chondroctyes and their use for promoting cartillage growth and repair20 Aug 2026US 2026/0240913 A1Cambridge Enterprise Limited
- Anti-Inflammatory Bio-Active Collagen Hybridizing Peptides and Methods of Using Thereof13 Aug 2026US 2026/0234215 A13Helix, Inc.
- Cd71 binding fibronectin type iii domains6 Aug 2026US 2026/0224718 A1ARO Biotherapeutics Company
Most cited
By later US patents
- Collagen-polymer conjugates778US 5,162,430 ACollagen Corporation · 1992
- Biologically inert, biocompatible-polymer conjugates521US 5,324,775 ACollagen Corporation · 1994
- Collagen-polymer conjugates471US 5,328,955 ACollagen Corporation · 1994
- Glycosaminoglycan-synthetic polymer conjugates284US 5,510,418 ACollagen Corporation · 1996
- Collagen-polymer conjugates208US 5,413,791 ACollagen Corporation · 1995